SCHEMBL7048131

SCHEMBL7048131

CONC(=O)c1c(C)c2c(n1Cc1ccc(Cl)c(Cl)c1)CCCC2=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.52
HDAC6 Q9UBN7 4/20 0.52
SLC6A2 P23975 1/20 0.42
SLC6A3 Q01959 1/20 0.42
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
RAB9A P51151 1/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
CCR2 P41597 5/20 0.38
ABCB11 O95342 1/20 0.37
RGS4 P49798 1/20 0.36
RGS8 P57771 1/20 0.36
P2RX7 Q99572 1/20 0.36
TSHR P16473 1/20 0.36
MCHR1 Q99705 1/20 0.36
ALDH1A1 P00352 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7050842 0.89 HDAC1 (0.48) HDAC1HDAC6LMNAMAPTRAB9A
SCHEMBL7045478 0.87 HDAC1 (0.47) HDAC1HDAC6LMNAMAPTRAB9A
SCHEMBL7954546 0.86 HDAC1 (0.46) HDAC1HDAC6LMNAMAPTRAB9A
SCHEMBL7048313 0.86 HDAC1 (0.52) HDAC1HDAC6LMNAMAPTRAB9A
SCHEMBL7050230 0.85 HDAC1 (0.45) HDAC1HDAC6LMNAMAPTRAB9A
SCHEMBL7046362 0.84 HDAC1 (0.51) HDAC1HDAC6LMNAMAPTRAB9A
SCHEMBL7050364 0.77 HDAC1 (0.42) HDAC1HDAC6LMNAMAPTRAB9A
SCHEMBL7049001 0.77 SMN1; SMN2 (0.45) HDAC1HDAC6LMNAMAPTRAB9A
SCHEMBL7048128 0.75 CCR2 (0.45) LMNAMAPTRAB9ASMN1; SMN2GAA
SCHEMBL7050359 0.75 HDAC1 (0.40) HDAC1HDAC6LMNAMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054667-B1 BICYCLIC PYRROLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANTIINFLAMMATORY AND IMMUNOMODULATING AGENTS ASTRAZENECA UK LTD (GB) 2003-04-16 EP disclosed
US-6291507-B1 INHIBITOR OF MONOCYTE CHEMOATTRACTANT PROTEIN-1; INDOLE DERIVATIVES ASTRAZENECA UK LIMITED (GB) 2001-09-18 US disclosed